19-11454818-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001420.4(ELAVL3):c.812C>T(p.Ala271Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000686 in 1,458,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001420.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELAVL3 | NM_001420.4 | c.812C>T | p.Ala271Val | missense_variant | 7/7 | ENST00000359227.8 | NP_001411.2 | |
ELAVL3 | NM_032281.3 | c.791C>T | p.Ala264Val | missense_variant | 7/7 | NP_115657.2 | ||
ELAVL3 | XM_011527778.3 | c.809C>T | p.Ala270Val | missense_variant | 7/7 | XP_011526080.1 | ||
ELAVL3 | XM_024451413.1 | c.788C>T | p.Ala263Val | missense_variant | 7/7 | XP_024307181.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELAVL3 | ENST00000359227.8 | c.812C>T | p.Ala271Val | missense_variant | 7/7 | 3 | NM_001420.4 | ENSP00000352162.1 | ||
ELAVL3 | ENST00000438662.6 | c.791C>T | p.Ala264Val | missense_variant | 7/7 | 5 | ENSP00000390878.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000410 AC: 1AN: 243782Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132326
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1458042Hom.: 0 Cov.: 33 AF XY: 0.00000552 AC XY: 4AN XY: 725230
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2024 | The c.812C>T (p.A271V) alteration is located in exon 7 (coding exon 7) of the ELAVL3 gene. This alteration results from a C to T substitution at nucleotide position 812, causing the alanine (A) at amino acid position 271 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at